FREENOME HOLDINGS INC.

Company Snapshot

Founded: 2014

Entity Type: Private

Region: U.S.

Segment: Cancer Detection

Headquarter: California, U.S.

Key Geographics: North America

Corporate Address: 3300 Marina Boulevard, Brisbane, California 94005, U.S. Tel. +1-855-242-8829 www.freenome.com

Company Overview

Freenome is focused on advancing early cancer detection through a suite of blood-based tests built on its multiomics platform. It integrates molecular biology, machine learning, and computational analysis, enabling it to detect subtle cancer signals at early stages. Its multimodal approach addresses cancer heterogeneity, improving screening accuracy. Through partnerships with healthcare organizations, Freenome aims to expand access to convenient, non-invasive cancer screening and enable broader population-level adoption.

FREENOME HOLDINGS INC. In Reports

Liquid Biopsy with Emphasis on Cancer: Global Markets

Analyse the global liquid biopsy market in cancer by indication, technology, biomarker, and application, with regional forecasts and competitive insights to 2031.

Global Colorectal Cancer Screening and Diagnostics Market

BCC Research Report: Dive into Colorectal Cancer Screening and Diagnostics Market estimates, data is provided for 2021 and 2022 as historical years, 2023 as the base year, and forecasts extend through 2029.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

View All Reports

FREENOME HOLDINGS INC. In News

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection - Yahoo Finance

Yahoo Finance - Jul 20, 2026

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform - PR Newswire

PR Newswire - Dec 05, 2025

Wilson Sonsini Advises Freenome on IP Matters Related to Business Combination, Public Company Launch - Wilson Sonsini

Wilson Sonsini - Jul 21, 2026

Freenome Holdings Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 31, 2026

Read All News

Company's Business Segments

Clinical Research Services : The company provides a clinical research program that drives yearly cancer detection tests' development, discovery, and validation.

Applications/End User Industries

Healthcare
Clinical Research & Diagnostics

Life Sciences

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment